Simplify-Asset-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "AKRO",
  "INSM",
  "ARQT",
  "ARGX",
  "NLY",
  "ALHC",
  "MDGL",
  "MMM",
  "ABT",
  "ABBV",
  "TGTX",
  "PCRX",
  "ADMA",
  "LGND",
  "PAGP",
  null,
  null,
  null,
  null,
  "LIVN",
  "TCRX",
  "ACHV",
  "PHAT",
  "SNDX",
  "ABEO",
  "GILD",
  "AGL",
  "ATHA",
  "APLT",
  "AZN",
  "ESTA",
  "FULC",
  "ISRG",
  "NBIX",
  "LPTX",
  "MIST",
  null,
  null,
  null,
  null,
  null,
  "BNTC",
  "IJR",
  "IVV",
  "UNH",
  "SPY",
  "MSTR",
  "DGX",
  "REGN",
  null,
  null,
  null,
  null,
  null,
  null,
  null,
  "GLD",
  "RITM",
  "SYK",
  "CI",
  "TMO",
  "ARR",
  "RNA",
  "AGNC",
  "PCT",
  "TWO",
  "PMT",
  null,
  "SNY",
  "RMD",
  "VRTX",
  "EW",
  "SRPT",
  "CAH",
  null,
  "DCTH",
  "EYPT",
  null,
  null,
  "RARE",
  "RVTY",
  "TFX",
  "CHWY",
  "ZBH",
  "CIM",
  "CMPX",
  "COO",
  "CVS",
  "DHR",
  "DXCM",
  "JNJ",
  "LLY",
  "TSLA",
  "PM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-13
Total Holdings: 94
Total Value: 2669821608
Accession Number: 0001172661-25-001739
Form Type: 13F-HR
CIK: simplify-asset-management
Manager Name: Simplify-Asset-Management

Data Enrichment

79% identified

74 identified20 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

94 positions • $2.7B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 5 of 5

Sort by:

EyePoint Pharmaceuticals, Inc.

EYPT|30233G209

Shares:88.2K

Value:$477.8K

% of Portfolio:0.0% ($477.8K/$2.7B)

STRYKER CORP

SYK|863667101

Shares:1.2K

Value:$451.2K

% of Portfolio:0.0% ($451.2K/$2.7B)

TG THERAPEUTICS, INC.

TGTX|88322Q108

Shares:11.3K

Value:$445.1K

% of Portfolio:0.0% ($445.1K/$2.7B)

Athira Pharma, Inc.

ATHA|04746L104

Shares:1.5M

Value:$425.3K

% of Portfolio:0.0% ($425.3K/$2.7B)

TWO HARBORS INVESTMENT CORP.

TWO|90187B804

Shares:31.0K

Value:$414.2K

% of Portfolio:0.0% ($414.2K/$2.7B)

LivaNova PLC

LIVN|G5509L101

Shares:9.4K

Value:$371.0K

% of Portfolio:0.0% ($371.0K/$2.7B)

LEAP THERAPEUTICS, INC.

LPTX|52187K200

Shares:951.0K

Value:$290.1K

% of Portfolio:0.0% ($290.1K/$2.7B)

ZIMMER BIOMET HOLDINGS, INC.

ZBH|98956P102

Shares:2.3K

Value:$263.3K

% of Portfolio:0.0% ($263.3K/$2.7B)

3M CO

MMM|88579Y101

Shares:1.8K

Value:$259.9K

% of Portfolio:0.0% ($259.9K/$2.7B)

Sarepta Therapeutics, Inc.

SRPT|803607100

Shares:4.1K

Value:$258.7K

% of Portfolio:0.0% ($258.7K/$2.7B)

Fulcrum Therapeutics, Inc.

FULC|359616109

Shares:81.1K

Value:$233.7K

% of Portfolio:0.0% ($233.7K/$2.7B)

Chewy, Inc.

CHWY|16679L109

Shares:7.1K

Value:$230.6K

% of Portfolio:0.0% ($230.6K/$2.7B)

Compass Therapeutics, Inc.

CMPX|20454B104

Shares:120.0K

Value:$228.0K

% of Portfolio:0.0% ($228.0K/$2.7B)

74915M100

Shares:600.0K

Value:$120.7K

% of Portfolio:0.0% ($120.7K/$2.7B)

Instrument	Shares		Other Manager	Value	% of Portfolio
EyePoint Pharmaceuticals, Inc.(EYPTcusip30233G209)	88.2K	QoQ NEW(+88.2K) YoY NEW(+88.2K)	All Managers (Combined)	$477.8K	0.0% ($477.8K/$2.7B)	QoQ NEW(+$477.8K) YoY NEW(+$477.8K)
STRYKER CORP(SYKcusip863667101)	1.2K	QoQ +0.49% (+6) YoY -76.18% (-3.9K)	All Managers (Combined)	$451.2K	0.0% ($451.2K/$2.7B)	QoQ +3.90% (+$16.9K) YoY -75.22% (-$1.4M)
TG THERAPEUTICS, INC.(TGTXcusip88322Q108)	11.3K	QoQ +0.45% (+51) YoY NEW(+11.3K)	All Managers (Combined)	$445.1K	0.0% ($445.1K/$2.7B)	QoQ +31.59% (+$106.9K) YoY NEW(+$445.1K)
Athira Pharma, Inc.(ATHAcusip04746L104)	1.5M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$425.3K	0.0% ($425.3K/$2.7B)	QoQ -51.44% (-$450.5K) YoY -89.60% (-$3.7M)
TWO HARBORS INVESTMENT CORP.(TWOcusip90187B804)	31.0K	QoQ +181.81% (+20.0K) YoY NEW(+31.0K)	All Managers (Combined)	$414.2K	0.0% ($414.2K/$2.7B)	QoQ +218.26% (+$284.0K) YoY NEW(+$414.2K)
LivaNova PLC(LIVNcusipG5509L101)	9.4K	QoQ +0.52% (-49) YoY +9.67% (-833)	All Managers (Combined)	$371.0K	0.0% ($371.0K/$2.7B)	QoQ -14.73% (-$64.1K) YoY -22.99% (-$110.8K)
LEAP THERAPEUTICS, INC.(LPTXcusip52187K200)	951.0K	QoQ +0.52% (-4.9K) YoY +152.93% (-575.0K)	All Managers (Combined)	$290.1K	0.0% ($290.1K/$2.7B)	QoQ -89.33% (-$2.4M) YoY -70.98% (-$710.0K)
ZIMMER BIOMET HOLDINGS, INC.(ZBHcusip98956P102)	2.3K	QoQ +0.82% (+19) YoY -90.98% (-23.5K)	All Managers (Combined)	$263.3K	0.0% ($263.3K/$2.7B)	QoQ +8.03% (+$19.6K) YoY -92.26% (-$3.1M)
3M CO(MMMcusip88579Y101)	1.8K	QoQ -93.15% (-24.1K) YoY -92.78% (-22.8K)	All Managers (Combined)	$259.9K	0.0% ($259.9K/$2.7B)	QoQ -92.21% (-$3.1M) YoY -88.05% (-$1.9M)
Sarepta Therapeutics, Inc.(SRPTcusip803607100)	4.1K	QoQ -87.63% (-28.7K) YoY -95.52% (-86.5K)	All Managers (Combined)	$258.7K	0.0% ($258.7K/$2.7B)	QoQ -93.50% (-$3.7M) YoY -97.79% (-$11.5M)
Fulcrum Therapeutics, Inc.(FULCcusip359616109)	81.1K	QoQ +0.52% (-420) YoY -87.99% (-594.9K)	All Managers (Combined)	$233.7K	0.0% ($233.7K/$2.7B)	QoQ -38.40% (-$145.7K) YoY -96.33% (-$6.1M)
Chewy, Inc.(CHWYcusip16679L109)	7.1K	QoQ -90.33% (-66.3K) YoY NEW(+7.1K)	All Managers (Combined)	$230.6K	0.0% ($230.6K/$2.7B)	QoQ -90.62% (-$2.2M) YoY NEW(+$230.6K)
Compass Therapeutics, Inc.(CMPXcusip20454B104)	120.0K	QoQ NEW(+120.0K) YoY NEW(+120.0K)	All Managers (Combined)	$228.0K	0.0% ($228.0K/$2.7B)	QoQ NEW(+$228.0K) YoY NEW(+$228.0K)
(cusip74915M100)✕	600.0K	QoQ 0.00% (-0) YoY NEW(+600.0K)	All Managers (Combined)	$120.7K	0.0% ($120.7K/$2.7B)	QoQ -39.06% (-$77.3K) YoY NEW(+$120.7K)